Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial
Title:
Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial
Author:
Platt, Heather Omole, Tosin Cardona, Jose Fraser, Neil J Mularski, Richard A Andrews, Charles Daboul, Nizar Gallagher, Nancy Sapre, Aditi Li, Jianing Polis, Adam Fernsler, Doreen Tamms, Gretchen Xu, Weifeng Murphy, Rocio Skinner, Julie Joyce, Joseph Musey, Luwy